Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.
Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.
Verona Pharma PLC (NASDAQ:VRNA) shares have reached an all-time high, touching a price level of $62.09. According to ...
Shares in biopharmaceutical group Axsome Therapeutics (AXSM) surged 23% today after it said it had settled a legal dispute ...
Sun Pharma is currently trading at Rs 1740.15, showing a slight decline of 0.22% today, with weekly returns down by 4.68%.
Vertex Pharmaceuticals continues to execute ... conservative analyst revenue projections, making the stock a STRONG BUY with a 12-month price of $550/share. As of yesterday evening, the FDA ...
Vertex set the U.S. wholesale price of Journavx at $15.50 per 50mg pill. Shares of Vertex Pharmaceuticals (VRTX) surged Friday, a day after the drugmaker reported federal regulators have approved ...
This anticipated adoption, along with a projected modest market penetration, underpins the increased price target for Vertex Pharmaceuticals’ stock, contributing to Fein’s Buy rating.
Explore Sun Pharma Industries stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the ...
The recent settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is a welcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results